Sooriakumaran, P., & Kaba, R. (2005). The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: A review.
Chicago Style (17th ed.) CitationSooriakumaran, P., and R. Kaba. The Risks and Benefits of Cyclo-oxygenase-2 Inhibitors in Prostate Cancer: A Review. 2005.
MLA (9th ed.) CitationSooriakumaran, P., and R. Kaba. The Risks and Benefits of Cyclo-oxygenase-2 Inhibitors in Prostate Cancer: A Review. 2005.
Warning: These citations may not always be 100% accurate.